Imaging
Imaging company receives U.S. FDA clearance for z3D Contrast Acuity
Published in Medical Letter on the CDC and FDA, January 15th, 2006
z3D will be initially distributed to customers through a license agreement with Confirma, Inc., and Invivo Corp.
z3D Contrast Acuity uses advanced computer graphics to enhance visualization of medical images to aid diagnosis and increase radiologist efficiency. z3D is used to assist in the efficient analysis of multimodality, digital images, including magnetic resonance imaging (MRI), computed tomography, x-ray, positron emission tomography, and nuclear medicine images.
"Clario is committed to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Amebiasis Diagnosis
Report compares real-time PCR protocols for differential diagnosis of amebiasis - Hemophilia Epidemiology
Report reviews demographics of hemophilia in developing countries - Streptococcus Epidemiology
Clonal association found between Streptococcus pneumoniae serotypes 23A and 23F - Vaccine Efficacy
Hepatitis A immunization program aimed at child-care centers proves successful - Acute Lymphoblastic Leukemia
European study confirms efficacy of clofarabine in pediatric patients with ALL - Acute Peripheral Arterial Occlusion
U.S. FDA specifies protocol for phase III trial of novel arterial perfusion with alfimeprase-3 - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
